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Key lessons learned from the INDIGO global network on mental health related stigma and 
discrimination 
 
Stigmatization of people with mental illness can contribute to adverse consequences 
including: poor access to mental and physical health care; reduced life expectancy; exclusion 
from higher education and employment; increased risk of contact with the criminal justice 
system; victimization; poverty and homelessness1.  
The WPA Open the Doors programme was initiated by one of us (NS) in 1999 and included 
both action and research components in 23 countries worldwide. This work led to the creation 
of the WPA Stigma Section, and to establishing a series of biannual international stigma 
related conferences, entitled Together Against Stigma.  
We subsequently created the INDIGO (International Study of Discrimination and Stigma 
Outcomes) Research Network to undertake research related to stigma and discrimination 
(http://www.indigo-group.org/). Here we summarize the work of the INDIGO network over 
the last decade, and set out what we have learned.  
In the first phase, colleagues in 27 countries worldwide agreed to join the network, and 
we realized that no suitable scales existed to measure mental illness related discrimination. 
We therefore created the Discrimination and Stigma Scale (DISC), which was found to have 
strong psychometric properties2. Since 2012, the DISC-12 scale has been accessed by 216 
research users in 55 countries worldwide. 
In our first global stigma project, the DISC-12 scale was used to interview 729 people with 
a clinical diagnosis of schizophrenia across 27 countries. The results showed that over 90% 
had experienced discrimination because of their mental health status3. Most people (72%) 
reported a need to conceal their diagnosis. The results confirmed the universality of 
discrimination adversely affecting people with schizophrenia.  
We next assessed 1,082 people with major depressive disorder in 35 countries, and found 
that 79% reported experiencing discrimination in at least one life domain. In exploring the 
data further, we unexpectedly found higher levels of experienced discrimination in high-
income compared with middle- and low-income countries (LMIC)4.  
We conceptualized stigma in relation to its three components of knowledge, attitudes 
and behaviour. We therefore created and psychometrically tested the following toolkit of 
scales and measures across those domains, to be freely available to researchers worldwide:  
 
 The Barriers to Access to Care Scale (BACE)5, formulated following a systematic review of 
barriers to help-seeking. 
 The Costs of Discrimination Assessment (CODA), assessing the costs related to mental 
illness related discrimination6. 
 The short version of the DISC-12 (DISCUS) scale, with strong psychometric properties and  
comparable reliability and validity to the original scale. 
 The Mental Health Knowledge Schedule (MAKS), assessing factual items related to mental 
health7. 
 The Mental Illness: Clinicians’ Attitudes (MICA) scales, evaluating attitudes among health 
care professionals or medical students towards people with mental illness8. 
 The Questionnaire of Anticipated Discrimination, exploring future expectation of 
discrimination (QUAD)9. 
 The Reported and Intended Behaviour Scale (RIBS), a short measure of the above 
domains10.  
 
These scales have been designed for global and open access use. They can be translated 
into any language, provided that each translation is copied to the repository at King’s College 
London, to be freely available for other researchers. Up to now, the INDIGO scales have been 
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translated into a total of 31 languages. They have been used in 67 countries during the last 
five years. The scales are available on request (maria.milenova@kcl.ac.uk).  
Following the toolkit phase of work, we more directly focused upon intervention studies. 
We produced a narrative and a systematic review of the global literature on interventions to 
reduce stigma and discrimination1 and a paper on intervention studies in LMICs.  
Taken as a whole, these reviews establish that: a) social contact (i.e., interpersonal 
contact between people with and without experience of mental illness) is the strongest 
proven active ingredient to reduce mental illness related stigma and discrimination; b) such 
social contact is most effective in educational settings for young people; c) there is emerging 
evidence that virtual/social media contact may be as effective as direct face-to-face contact; 
and d) there is a research gap on all of these issues in LMICs.  
Since the INDIGO network was established, we have learned the following lessons on how 
a network may become successful, productive and sustainable.  
 
 Clear ground rules are vital in terms of what are the role and responsibilities of all partners.  
 Establishing a learning collaborative: we actively encourage sites to support each other, 
particularly in similar language or resource-level settings.  
 Taking a long-term view for sustainable capacity building: for an international research 
network to survive, let alone thrive, it is necessary to purposively support early- and mid-
career academic staff.  
 A distributed model of leadership for shared responsibilities and co-operation: we have 
found it useful to distribute specific roles into discrete work packages, and to establish task 
teams for each of these tasks.  
 Freedom within a framework: the coordinating centre agrees with project staff what their 
ultimate products or deliverables will be, when they will be delivered, and the intermediate 
steps, or milestones that will have to be completed to a given set of time points. 
 Multidisciplinary approach to research: the network provides a unique resource for the 
development of new research in the field of stigma by bringing a variety of inter-
disciplinary skills.  
 Regular communication: it is vital to build a sense of belonging to a valued group of 
colleagues, and to celebrate intermediate as well as final project successes. 
 
From our work in the INDIGO network so far, we have learned that stigma and 
discrimination are universal, that they are reversible, and that there are some variations in 
their manifestations across cultures. We continue to welcome colleagues who wish to join this 
network, and we are now considering how the learning generated by the network may be 
used to counteract stigma in other arenas. 
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